Fund Basics
See More- Fund Family N/A
- Assets Under Management 0
- Shares Outstanding, K 650
- 60-Month Beta 0.43
- Price/Earnings ttm N/A
- Annual Dividend & Yield 0.66 (3.16%)
- Most Recent Dividend N/A on N/A
- Management Fee N/A
Period | Period Low | Period High | Performance | |
---|---|---|---|---|
1-Month | 20.64 +1.28% on 05/10/22 |
Period Open: 22.63
| 22.98 -9.03% on 04/20/22 | -1.73 (-7.65%) since 04/08/22 |
3-Month | 20.64 +1.28% on 05/10/22 |
Period Open: 21.99
| 22.98 -9.03% on 04/20/22 | -1.09 (-4.93%) since 02/10/22 |
52-Week | 20.34 +2.77% on 06/09/21 |
Period Open: 21.53
| 22.98 -9.03% on 04/20/22 | -0.63 (-2.91%) since 05/10/21 |
First Trust Advisors L.P. (“FTA”) announced today that First Trust Hedged BuyWrite Income ETF (Nasdaq: FTLB) (the “Fund”), a series of First Trust Exchange-Traded Fund VI (the “Trust”), will...
First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 120 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 133 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 122 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distributions for certain exchange-traded funds advised by FTA.
/PRNewswire/ -- USA News Group - Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their "Cancer Moonshot"...
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 20, 2023 – USA News Group – Earlier this year, the US White House requested over $2.8 billion in funding from...
Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.17%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.18% at a 1-week high. Stock indexes this morning are moderately...
/PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel...
Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.
A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...
ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t
What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.205%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.59%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.2%. After...
/PRNewswire/ -- USA News Group - Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their "Cancer Moonshot"...
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 20, 2023 – USA News Group – Earlier this year, the US White House requested over $2.8 billion in funding from...
Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.17%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.18% at a 1-week high. Stock indexes this morning are moderately...
/PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel...
Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.
A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...
ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t
What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.205%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.59%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.2%. After...
/PRNewswire/ -- USA News Group - Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their "Cancer Moonshot"...
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 20, 2023 – USA News Group – Earlier this year, the US White House requested over $2.8 billion in funding from...
Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.17%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.18% at a 1-week high. Stock indexes this morning are moderately...
/PRNewswire/ - ImmunoBiochem Corporation, a privately-held biopharmaceutical company focused on the discovery of unique tumor targets and development of novel...
Clinical-stage biotech MoonLake Immunotherapeutics AG (NASDAQ: MLTX) shares spiked 70% on positive clinical trial results.
A significant medical breakthrough is needed in the fight against metastatic breast cancer. According to the American Cancer Society, more than 3.1 million women in the United States have a history of...
ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t
What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.205%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.59%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.2%. After...
Name | % Holdings |
---|
3rd Resistance Point | 21.38 |
2nd Resistance Point | 21.18 |
1st Resistance Point | 21.04 |
Last Price | 20.90 |
1st Support Level | 20.70 |
2nd Support Level | 20.50 |
3rd Support Level | 20.36 |
52-Week High | 22.98 |
Fibonacci 61.8% | 21.97 |
Fibonacci 50% | 21.66 |
Fibonacci 38.2% | 21.35 |
Last Price | 20.90 |
52-Week Low | 20.34 |